Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Menon

Showing results (421-430 of 497) with videos related to

Pageof 50
Sort By:
Cancer Medicine|April 20, 2019
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American WomenDelores J Grant, Ani Manichaikul, Anthony J Alberg, et al.
British Journal of Cancer|June 20, 2020
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis ConsortiumFilipe Correia Martins, Dominique-Laurent Couturier, Anna Paterson, et al.
Journal of the National Cancer Institute|October 10, 2022
Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk LociAmber A DeVries, Joe Dennis, Jonathan P Tyrer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2016
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer SurvivalLara E Sucheston-Campbell, Rikki Cannioto, Alyssa I Clay, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2014
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerMatthew S Block, Bridget Charbonneau, Robert A Vierkant, et al.
Oncotarget|December 3, 2016
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaborationJennifer B Permuth, Brett Reid, Madalene Earp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2015
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association ConsortiumSharon E Johnatty, Jonathan P Tyrer, Siddhartha Kar, et al.
The Journal of Pathology. Clinical Research|August 1, 2018
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium studyPeter F Rambau, Robert A Vierkant, Maria P Intermaggio, et al.
JAMA Oncology|October 20, 2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer, Ellen L Goode, Matthew S Block, et al.
Pageof 50

Showing results (421-430 of 497) with videos related to

Sort By:
Pageof 50
Cancer Medicine|April 20, 2019
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American WomenDelores J Grant, Ani Manichaikul, Anthony J Alberg, et al.
British Journal of Cancer|June 20, 2020
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis ConsortiumFilipe Correia Martins, Dominique-Laurent Couturier, Anna Paterson, et al.
Journal of the National Cancer Institute|October 10, 2022
Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk LociAmber A DeVries, Joe Dennis, Jonathan P Tyrer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2016
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer SurvivalLara E Sucheston-Campbell, Rikki Cannioto, Alyssa I Clay, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2014
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerMatthew S Block, Bridget Charbonneau, Robert A Vierkant, et al.
Oncotarget|December 3, 2016
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaborationJennifer B Permuth, Brett Reid, Madalene Earp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2015
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association ConsortiumSharon E Johnatty, Jonathan P Tyrer, Siddhartha Kar, et al.
The Journal of Pathology. Clinical Research|August 1, 2018
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium studyPeter F Rambau, Robert A Vierkant, Maria P Intermaggio, et al.
JAMA Oncology|October 20, 2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer, Ellen L Goode, Matthew S Block, et al.
Pageof 50